Coronary flow reserve by transthoracic echocardiography predicts epicardial intimal thickening in cardiac allograft vasculopathy

F. Tona, E. Osto, G. Tarantini, A. Gambino, F. Cavallin, G. Feltrin, R. Montisci, A. L P Caforio, G. Gerosa, S. Iliceto

Research output: Contribution to journalArticlepeer-review

Abstract

Cardiac allograft vasculopathy (CAV) is the leading cause of morbidity and mortality in heart transplantation (HT).We sought to investigate the role of coronary flow reserve (CFR) by contrast-enhanced transthoracic echocardiography (CE-TTE) in CAV diagnosis. CAV was defined as maximal intimal thickness (MIT) assessed by intravascular ultrasound (IVUS) ≥0.5 mm. CFR was assessed in the left anterior descending coronary artery in 22 HT recipients at 6 ± 4 years post- HT. CAV was diagnosed in 10 patients (group A), 12 had normal coronaries (group B). The mean MIT was 0.7 ± 0.1mm(range 0.03-1.8).MITwas higher in group A (1.16 ± 0.3 mm vs. 0.34 ± 0.07 mm, p <0.0001). CFR was 3.1 ± 0.8 in all patients and lower in group A (2.5 ± 0.6 vs. 3.7 ± 0.3, p <0.0001). CFR was inversely related with MIT (r=-0.774, p <0.0001). A cut point of ≤2.9, identified as optimal by receiver operating characteristics analysis was 100% specific and 80% sensitive (PPV = 100%, NPV = 89%, Accuracy = 91%). CFR assessment by CE-TTE is a novel noninvasive diagnostic tool in the detection of CAV defined as MIT ≥0.5 mm. CFR by CE-TTE may reduce the need for routine IVUS in HT.

Original languageEnglish
Pages (from-to)1668-1676
Number of pages9
JournalAmerican Journal of Transplantation
Volume10
Issue number7
DOIs
Publication statusPublished - Jul 2010

Keywords

  • Cardiac allograft vasculopathy
  • Coronary flow reserve
  • Diagnosis
  • Follow-up studies
  • Heart transplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Coronary flow reserve by transthoracic echocardiography predicts epicardial intimal thickening in cardiac allograft vasculopathy'. Together they form a unique fingerprint.

Cite this